Patent ductus arteriosus in the neonate.
Recently there has been a significant reappraisal of the role of PDA in the context of neonatal cardiopulmonary disease. This article reviews surgical intervention, pharmacologic treatment, and assessment of ductal patency in the neonate.
D000527:Alprostadil / Q000627:therapeutic use; D001775:Blood Circulation; D002986:Clinical Trials as Topic; D004077:Digoxin / Q000627:therapeutic use; D004373:Ductus Arteriosus / Q000503:physiopathology / Q000601:surgery; D004374:Ductus Arteriosus, Patent / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D006330:Heart Defects, Congenital / Q000150:complications / Q000503:physiopathology; D006334:Heart Function Tests; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000503:physiopathology*; D008026:Ligation; D010547:Persistent Fetal Circulation Syndrome; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D011897:Random Allocation; D012127:Respiratory Distress Syndrome, Newborn / Q000503:physiopathology
D011448:Prostaglandin Antagonists; D004077:Digoxin; D000527:Alprostadil; D007213:Indomethacin